VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.

Tangri N, Mathur VS, Bushinsky DA, Klaerner G, Li E, Parsell D, Stasiv Y, Walker M, Wesson DE, Wheeler DC, Perkovic V, Inker LA

Open source

DOI: 10.1681/asn.0000000000000292
Published: 2024 Mar 1
Container: Journal of the American Society of Nephrology : JASN
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1681/asn.0000000000000292,
  title = {VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.},
  author = {Tangri N and Mathur VS and Bushinsky DA and Klaerner G and Li E and Parsell D and Stasiv Y and Walker M and Wesson DE and Wheeler DC and Perkovic V and Inker LA},
  year = {2024},
  journal = {Journal of the American Society of Nephrology : JASN},
  doi = {10.1681/asn.0000000000000292},
  url = {https://doi.org/10.1681/asn.0000000000000292}
}

RIS

TY  - JOUR
TI  - VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
AU  - Tangri N
AU  - Mathur VS
AU  - Bushinsky DA
AU  - Klaerner G
AU  - Li E
AU  - Parsell D
AU  - Stasiv Y
AU  - Walker M
AU  - Wesson DE
AU  - Wheeler DC
AU  - Perkovic V
AU  - Inker LA
PY  - 2024
JO  - Journal of the American Society of Nephrology : JASN
DO  - 10.1681/asn.0000000000000292
UR  - https://doi.org/10.1681/asn.0000000000000292
ER  -

APA

N, T., VS, M., DA, B., G, K., E, L., D, P., Y, S., M, W., DE, W., DC, W., V, P., & LA, I. (2024). VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.. Journal of the American Society of Nephrology : JASN. https://doi.org/10.1681/asn.0000000000000292

Source records

pubmed · retrieved 2026-09-26T20:09:01.126Z